These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24191917)

  • 1. Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients.
    He HC; Han ZD; Dai QS; Ling XH; Fu X; Lin ZY; Deng YH; Qin GQ; Cai C; Chen JH; Jiang FN; Liu X; Zhong WD
    BMC Genomics; 2013 Nov; 14():757. PubMed ID: 24191917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
    Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
    PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
    Kulda V; Topolcan O; Kucera R; Kripnerova M; Srbecka K; Hora M; Hes O; Klecka J; Babuska V; Rousarova M; Benson V; Pesta M
    Anticancer Res; 2016 Sep; 36(9):4787-93. PubMed ID: 27630329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.
    Melbø-Jørgensen C; Ness N; Andersen S; Valkov A; Dønnem T; Al-Saad S; Kiselev Y; Berg T; Nordby Y; Bremnes RM; Busund LT; Richardsen E
    PLoS One; 2014; 9(11):e113039. PubMed ID: 25401698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
    Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
    Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of microRNAs as human prostate cancer biomarkers: A meta-analysis of related studies.
    Song CJ; Chen H; Chen LZ; Ru GM; Guo JJ; Ding QN
    J Cell Biochem; 2018 Mar; 119(3):2763-2786. PubMed ID: 29095529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours.
    Sun R; Fu X; Li Y; Xie Y; Mao Y
    BMC Genomics; 2009 Feb; 10():93. PubMed ID: 19245699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.
    Vilming Elgaaen B; Olstad OK; Haug KB; Brusletto B; Sandvik L; Staff AC; Gautvik KM; Davidson B
    BMC Cancer; 2014 Feb; 14():80. PubMed ID: 24512620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially expressed miR-20, miR-21, miR-100, miR-125a and miR-146a as a potential biomarker for prostate cancer.
    Damodaran M; Chinambedu Dandapani M; SimonDuraiRaj ; SandhyaSundaram ; VenkatRamanan S; Ramachandran I; Venkatesan V
    Mol Biol Rep; 2021 Apr; 48(4):3349-3356. PubMed ID: 33948855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
    Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
    Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
    Wang BD; Ceniccola K; Yang Q; Andrawis R; Patel V; Ji Y; Rhim J; Olender J; Popratiloff A; Latham P; Lai Y; Patierno SR; Lee NH
    Clin Cancer Res; 2015 Nov; 21(21):4970-84. PubMed ID: 26089375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
    Aghaee-Bakhtiari SH; Arefian E; Naderi M; Noorbakhsh F; Nodouzi V; Asgari M; Fard-Esfahani P; Mahdian R; Soleimani M
    Tumour Biol; 2015 Jun; 36(6):4203-12. PubMed ID: 25604141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
    Schubert M; Spahn M; Kneitz S; Scholz CJ; Joniau S; Stroebel P; Riedmiller H; Kneitz B
    PLoS One; 2013; 8(6):e65064. PubMed ID: 23798998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.
    Fu J; Tang W; Du P; Wang G; Chen W; Li J; Zhu Y; Gao J; Cui L
    BMC Syst Biol; 2012 Jun; 6():68. PubMed ID: 22703586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence.
    Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A
    Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.